Related Experiment Video
Updated: Jun 20, 2026
09:31
Characterization of Amyloid Structures in Aging C. Elegans Using Fluorescence Lifetime Imaging
Published on: March 27, 2020
Probing Alzheimer amyloid peptide aggregation using a cell-free fluorescent protein refolding method
Pharhad Eli Arslan1, Avijit Chakrabartty
1Ontario Cancer Institute and Department of Medical Biophysics, University of Toronto, 101 College Street, Toronto, ON M5G 1L7, Canada.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire
|September 22, 2009
Summary
Researchers developed a novel cell-free assay using a fluorescent protein fusion to monitor Alzheimer's beta-amyloid (Abeta) aggregation. This method accurately detects Abeta aggregation and the effect of substances like Zn2+ on its formation.
Area of Science:
- Biochemistry
- Neuroscience
- Molecular Biology
Background:
- Alzheimer's disease pathogenesis involves amyloid beta (Abeta) fibrillation and toxic oligomer formation.
- Existing Abeta aggregation assays often use chemically synthesized peptides that are unstable at neutral pH.
- Developing robust cell-free assays is crucial for identifying Alzheimer's disease therapeutics.
Purpose of the Study:
- To develop a novel, sensitive cell-free assay for monitoring Alzheimer's beta-amyloid (Abeta) aggregation.
- To validate the assay's ability to detect aggregation influenced by metal ions.
- To provide a reliable method for screening potential Abeta aggregation inhibitors.
Main Methods:
- Genetically fused Abeta42 to a variant of Green Fluorescent Protein (vYFP).
- Expressed and purified the Abeta42-vYFP fusion protein for cell-free assays.
- Utilized fluorescence protein refolding as a readout for Abeta42 aggregation.
Main Results:
- Refolding efficiency of Abeta42-vYFP correlated inversely with Abeta42 solubility.
- The assay successfully detected Zn2+-induced Abeta42 aggregation with an IC50 of 3.03 ± 0.65 µmol/L.
- Confirmed the assay's capability to monitor aggregation of chemically synthesized Abeta42.
Conclusions:
- The novel fluorescence protein refolding assay provides a sensitive method for studying Abeta42 aggregation.
- This cell-free system is suitable for screening aggregation inhibitors and understanding factors influencing Abeta pathology.
- The assay demonstrates the aggregation-promoting effect of Zn2+ on Abeta42.
